CY1123673T1 - Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος - Google Patents
Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματοςInfo
- Publication number
- CY1123673T1 CY1123673T1 CY20201101028T CY201101028T CY1123673T1 CY 1123673 T1 CY1123673 T1 CY 1123673T1 CY 20201101028 T CY20201101028 T CY 20201101028T CY 201101028 T CY201101028 T CY 201101028T CY 1123673 T1 CY1123673 T1 CY 1123673T1
- Authority
- CY
- Cyprus
- Prior art keywords
- proton
- oral administration
- binding polymer
- treating
- methods
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F226/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen
- C08F226/02—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen by a single or double bond to nitrogen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/02—Polyamines
- C08G73/024—Polyamines containing oxygen in the form of ether bonds in the main chain
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G01N2001/4083—Concentrating samples by other techniques involving separation of suspended solids sedimentation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/40—Concentrating samples
- G01N1/4077—Concentrating samples by other techniques involving separation of suspended solids
- G01N2001/4088—Concentrating samples by other techniques involving separation of suspended solids filtration
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Abstract
Φαρμακευτικές συνθέσεις για θεραπεία και μέθοδοι θεραπείας ενός ζώου, που συμπεριλαμβάνουν άνθρωπο, και μέθοδοι παρασκευής τέτοιων συνθέσεων. Οι φαρμακευτικές συνθέσεις περιέχουν εγκάρσια συνδεδεμένης αμίνης πολυμερή που μπορεί να χρησιμοποιηθούν για παράδειγμα για να θεραπεύονται ασθένειες ή άλλες μεταβολικές καταστάσεις όπου η απομάκρυνση πρωτονίων ή/και χλωριούχων ιόντων από τη γαστρεντερική οδό θα παρέχει φυσιολογικά οφέλη όπως κανονικοποιημένες συγκεντρώσεις όξινου ανθρακικού του ορού και του pΗ του αίματος σε ένα συμπεριλαμβανομένου ανθρώπου.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361831445P | 2013-06-05 | 2013-06-05 | |
PCT/US2014/041152 WO2014197725A1 (en) | 2013-06-05 | 2014-06-05 | Proton-binding polymers for oral administration |
EP17177221.3A EP3287133B1 (en) | 2013-06-05 | 2014-06-05 | Proton-binding polymers for oral administration |
EP14742001.2A EP3003327B1 (en) | 2013-06-05 | 2014-06-05 | Proton-binding polymers for oral administration |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1123673T1 true CY1123673T1 (el) | 2022-03-24 |
Family
ID=51212941
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171101159T CY1119611T1 (el) | 2013-06-05 | 2017-11-06 | Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος |
CY20191100694T CY1121801T1 (el) | 2013-06-05 | 2019-07-04 | Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος |
CY20201101028T CY1123673T1 (el) | 2013-06-05 | 2020-10-30 | Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171101159T CY1119611T1 (el) | 2013-06-05 | 2017-11-06 | Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος |
CY20191100694T CY1121801T1 (el) | 2013-06-05 | 2019-07-04 | Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος |
Country Status (25)
Country | Link |
---|---|
US (8) | US9205107B2 (el) |
EP (4) | EP3812761A1 (el) |
JP (4) | JP6453860B2 (el) |
KR (4) | KR102318910B1 (el) |
CN (3) | CN105377270B (el) |
AU (3) | AU2014274817B2 (el) |
BR (1) | BR112015030142B1 (el) |
CA (1) | CA2912911C (el) |
CY (3) | CY1119611T1 (el) |
DK (3) | DK3578185T3 (el) |
ES (3) | ES2733493T3 (el) |
HK (3) | HK1222120A1 (el) |
HR (3) | HRP20171590T1 (el) |
HU (3) | HUE043999T2 (el) |
IL (3) | IL242758B (el) |
LT (3) | LT3003327T (el) |
MX (3) | MX364785B (el) |
NO (1) | NO2905572T3 (el) |
PL (2) | PL3003327T3 (el) |
PT (3) | PT3287133T (el) |
RS (2) | RS61005B1 (el) |
RU (1) | RU2728778C2 (el) |
SI (3) | SI3287133T1 (el) |
TR (1) | TR201909355T4 (el) |
WO (1) | WO2014197725A1 (el) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014274817B2 (en) * | 2013-06-05 | 2019-05-23 | Tricida, Inc. | Proton-binding polymers for oral administration |
ES2857177T3 (es) | 2014-12-10 | 2021-09-28 | Tricida Inc | Polímeros de unión de protones para administración oral |
SG11201809605PA (en) * | 2016-05-06 | 2018-11-29 | Tricida Inc | Compositions for and method of treating acid-base disorders |
WO2018124264A1 (ja) | 2016-12-28 | 2018-07-05 | 富士フイルム株式会社 | 窒素原子含有ポリマー又はその塩の乳化液、その製造方法、及び粒子の製造方法 |
US10934380B1 (en) | 2017-09-25 | 2021-03-02 | Tricida, Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
TW201922267A (zh) | 2017-10-16 | 2019-06-16 | 日商富士軟片股份有限公司 | 高磷血症治療劑 |
US20210187011A1 (en) * | 2017-11-03 | 2021-06-24 | Tricida, Inc. | Method of treating acid-base disorders |
SG11202003451UA (en) | 2017-11-03 | 2020-05-28 | Tricida Inc | Compositions for and method of treating acid-base disorders |
WO2019236636A1 (en) * | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
JP2022540707A (ja) * | 2019-07-19 | 2022-09-16 | アカテコール・インコーポレイテッド | 分子的に十分に規定された生物付着防止ポリイオンコーティング |
EP4053179A1 (en) | 2021-03-01 | 2022-09-07 | Tricida Inc. | Crosslinked poly(allylamine) polymer pharmaceutical compositions |
WO2023109825A1 (zh) * | 2021-12-14 | 2023-06-22 | 上海石趣医药科技有限公司 | 氧化银和/或其水合物在制备药物中的用途 |
CN115260355A (zh) * | 2022-05-16 | 2022-11-01 | 江苏中天药业有限公司 | 一种阴离子交换树脂、其制备方法、该树脂与药物的复合物和其掩味制剂 |
KR20230047972A (ko) | 2023-03-21 | 2023-04-10 | 최문수 | 개인별 맞춤형 그립 형상이 형성된 운동기구용 손잡이 |
Family Cites Families (120)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050090553A1 (en) | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
US6444221B1 (en) | 1992-06-30 | 2002-09-03 | Howard K. Shapiro | Methods of treating chronic inflammatory diseases using carbonyl trapping agents |
CA2202397C (en) | 1994-10-17 | 2002-07-16 | Peter W. Stacpoole | Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders |
US5534259A (en) * | 1993-07-08 | 1996-07-09 | Liposome Technology, Inc. | Polymer compound and coated particle composition |
US5496545A (en) | 1993-08-11 | 1996-03-05 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
US5648355A (en) | 1994-02-09 | 1997-07-15 | Kos Pharmaceutical, Inc. | Method of treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
TW474813B (en) | 1994-06-10 | 2002-02-01 | Geltex Pharma Inc | Alkylated composition for removing bile salts from a patient |
US20020006899A1 (en) | 1998-10-06 | 2002-01-17 | Pospisilik Andrew J. | Use of dipeptidyl peptidase IV effectors for lowering blood pressure in mammals |
US5753706A (en) | 1996-12-16 | 1998-05-19 | Hsu; Chen Hsing | Methods for treating renal failure |
AUPO758297A0 (en) | 1997-06-27 | 1997-07-24 | Rowe, James Baber | Control of acidic gut syndrome |
US6726905B1 (en) | 1997-11-05 | 2004-04-27 | Genzyme Corporation | Poly (diallylamines)-based phosphate binders |
WO1999040990A1 (en) | 1998-02-17 | 1999-08-19 | University Of Maryland | Anion binding polymers and the use thereof |
US6485703B1 (en) | 1998-07-31 | 2002-11-26 | The Texas A&M University System | Compositions and methods for analyte detection |
US6271264B1 (en) | 1998-12-01 | 2001-08-07 | Geltex Pharmaceuticals, Inc. | Polymers containing spirobicyclic ammonium moieties as bile acid sequestrants |
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
GB9927088D0 (en) | 1999-11-17 | 2000-01-12 | Secr Defence | Use of poly(diallylamine) polymers |
US6844372B2 (en) | 2000-03-09 | 2005-01-18 | Hisamitsu Pharmaceutical Co., Inc. | Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same |
WO2001066606A1 (fr) | 2000-03-09 | 2001-09-13 | Hisamitsu Pharmaceutical Co., Inc. | Resine echangeuse d'anions reticulee ou sel de celle-ci |
AU2001241095A1 (en) | 2000-03-13 | 2001-09-24 | Hisamitsu Pharmaceutical Co. Inc. | Preventives and/or remedies for hyperphosphatemia |
JP2002028737A (ja) | 2000-07-07 | 2002-01-29 | Fujitsu Ltd | プレス打ち抜き加工方法及びプレス打ち抜き加工装置 |
BR0209133A (pt) | 2001-04-18 | 2004-06-15 | Genzyme Corp | Método para tratar gota e para reduzir os nìveis de ácido úrico n0 sangue |
BR0209020A (pt) * | 2001-04-18 | 2004-08-10 | Genzyme Corp | Composição farmacêutica de polialilamina |
CN1274668C (zh) | 2002-03-11 | 2006-09-13 | 诺瓦提斯公司 | 那格列奈的盐 |
US20070135335A1 (en) | 2003-02-10 | 2007-06-14 | Autogen Research Pty Ltd. | Therapeutic molecules |
TWI335218B (en) | 2003-02-19 | 2011-01-01 | Panion & Bf Biotech Inc | Ferric organic compounds, uses thereof and methods of making same |
CN1540136A (zh) * | 2003-10-27 | 2004-10-27 | 华东理工大学 | 一种评价微生物驱油能力的方法 |
US7767768B2 (en) | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
US7385012B2 (en) | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
US7449605B2 (en) | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
US7608674B2 (en) * | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
US7459502B2 (en) | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
CA2551528A1 (en) | 2003-12-31 | 2005-07-21 | Genzyme Corporation | Enteric coated aliphatic amine polymer bile acid sequestrants |
EP1723968A1 (en) | 2004-01-29 | 2006-11-22 | Keio University | Erythrocyte function modifying substance |
US7854924B2 (en) | 2004-03-30 | 2010-12-21 | Relypsa, Inc. | Methods and compositions for treatment of ion imbalances |
US8282960B2 (en) | 2004-03-30 | 2012-10-09 | Relypsa, Inc. | Ion binding compositions |
JP5000480B2 (ja) | 2004-03-30 | 2012-08-15 | レリプサ, インコーポレイテッド | イオンバランス異常の治療の方法および組成物 |
US7429394B2 (en) | 2004-03-30 | 2008-09-30 | Relypsa, Inc. | Ion binding compositions |
US8192758B2 (en) | 2004-03-30 | 2012-06-05 | Relypsa, Inc. | Ion binding compositions |
US7556799B2 (en) | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
US8399025B2 (en) | 2004-06-04 | 2013-03-19 | Board Of Regents, The University Of Texas System | Polyamine modified particles |
CN101022821B (zh) | 2004-07-19 | 2014-01-29 | 纽崔西亚公司 | 天冬氨酸用于调节血中葡萄糖水平的用途 |
DE102004035808A1 (de) | 2004-07-21 | 2006-03-16 | Kasch, Helmut, Dr. | Ammoniumsalze und Ammoniumsalz-Mineralsalzchlatrate als Transport- und Wirkform für pharmazeutische-medizinische und als Phasentransfermittel für chemische Anwendungen |
US8569277B2 (en) | 2004-08-11 | 2013-10-29 | Palo Alto Investors | Methods of treating a subject for a condition |
US20080214440A1 (en) | 2004-10-08 | 2008-09-04 | Forbes Medi-Tech (Research), Inc. | Vasoactive intestinal polypeptide compositions |
US20070293429A1 (en) | 2004-10-08 | 2007-12-20 | Therapei Pharmaceuticals, Inc. | Vasoactive Intestinal Polypeptide Compositions |
AU2005296290A1 (en) * | 2004-10-13 | 2006-04-27 | Ilypsa, Inc. | Crosslinked amine polymers |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
ITME20040015A1 (it) | 2004-12-07 | 2005-03-07 | Vincenzo Savica | Chewing gum, caramelle gommose, pastiglie, compresse a lento rilascio di chelanti fosfato e/o fosforo salivare e capsule a lento rilascio di chelanti fosfato e/o fosforo a livello gastroenterico. |
AU2006264407B2 (en) | 2005-07-04 | 2012-08-30 | Ramu Krishnan | Improved drug or pharmaceutical compounds and a preparation thereof |
CA2619591C (en) | 2005-08-18 | 2020-03-24 | Globoasia, Llc | Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same |
WO2007027566A2 (en) | 2005-09-02 | 2007-03-08 | Genzyme Corporation | Method for removing phosphate and polymer used therefore |
WO2007038801A2 (en) | 2005-09-30 | 2007-04-05 | Ilypsa, Inc. | Monovalent cation-binding compositions comprising core-shell particles having crosslinked poly-vinylic shells, and methods of use thereof |
CA2624170C (en) * | 2005-09-30 | 2014-02-25 | Ilypsa, Inc. | Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
DE112006002617T5 (de) | 2005-09-30 | 2008-08-28 | Ilypsa Inc., Santa Clara | Verfahren zur Herstellung von Core-Shell-Kompositen bzw. Kern-Hüllen-Kompositen mit vernetzten Hüllen und daraus entstehende Core-Shell-Komposite |
KR101119847B1 (ko) | 2005-11-08 | 2012-03-14 | 아지노모토 가부시키가이샤 | 마취 각성 촉진제 |
BRPI0618352A2 (pt) | 2005-11-08 | 2011-08-23 | Genzyme Corp | composições farmacêuticas e métodos de tratamento da hiperfosfatemia em um paciente |
ITMI20052461A1 (it) | 2005-12-22 | 2007-06-23 | Univ Degli Studi Milano | Sistemi microparticellari per la somministrazione orale di sostanze biologicamente attive |
RU2008136081A (ru) | 2006-02-14 | 2010-03-20 | Тева Фармасьютикл Индастриес Лтд. (Il) | Фармацевтические составы с алифатическими аминными полимерами и способы их производства |
US20080085259A1 (en) | 2006-05-05 | 2008-04-10 | Huval Chad C | Amine condensation polymers as phosphate sequestrants |
JP2009542653A (ja) | 2006-07-05 | 2009-12-03 | ジェンザイム コーポレーション | リン酸塩過剰血症のための鉄(ii)含有治療剤 |
MX2009000611A (es) | 2006-07-18 | 2009-04-16 | Genzyme Corp | Dendrimeros de amina. |
CN101541235A (zh) * | 2006-07-18 | 2009-09-23 | 基酶有限公司 | 胺类树状物 |
US8391873B2 (en) | 2006-07-21 | 2013-03-05 | Qualcomm Incorporated | Systems and methods for coordinating supplementary services for voice telephone calls in a centralized fashion |
WO2008016729A1 (en) | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Compositions for intranasal delivery of human insulin and uses thereof |
US7964182B2 (en) * | 2006-09-01 | 2011-06-21 | USV, Ltd | Pharmaceutical compositions comprising phosphate-binding polymer |
EP2068819A4 (en) * | 2006-09-01 | 2011-04-20 | Genzyme Corp | Dendrimer COMPOSITIONS |
RU2009111853A (ru) | 2006-09-01 | 2010-10-10 | Юсв Лимитед (In) | Способ получения гидрохлорида севеламера и его лекарственной формы |
US7868045B2 (en) | 2006-09-06 | 2011-01-11 | Sucampo Ag | Method for promoting gastrointestinal bicarbonate secretion |
BRPI0717545A2 (pt) | 2006-09-29 | 2013-10-22 | Gezyme Corp | Composição farmacêutica, método para tratar uma doença, polímero de amida, rede de polímero, e, método para preparar um polímero de amida |
US8163799B2 (en) | 2006-12-14 | 2012-04-24 | Genzyme Corporation | Amido-amine polymer compositions |
US20100129309A1 (en) | 2007-02-23 | 2010-05-27 | Dhal Pradeep K | Amine polymer compositions |
US20080207766A1 (en) | 2007-02-27 | 2008-08-28 | Agi Therapeutics Research Ltd. | Methods and compositions for treating at least one upper gastrointestinal symptom |
WO2008109095A1 (en) | 2007-03-08 | 2008-09-12 | Genzyme Corporation | Sulfone polymer compositions |
TWI445540B (zh) | 2007-04-20 | 2014-07-21 | Ajinomoto Kk | 抗低體溫組成物 |
US20100166696A1 (en) | 2007-04-27 | 2010-07-01 | Dhal Pradeep K | Amido-amine dendrimer compositions |
WO2009005838A2 (en) | 2007-07-02 | 2009-01-08 | Cognate3 Llc | Process for the preparation of a non-corrosive base solution and methods of using same |
KR20100045965A (ko) * | 2007-07-11 | 2010-05-04 | 도레이 카부시키가이샤 | 가교 폴리알릴아민 또는 그 산부가염 및 그 의약 용도 |
EP2016947A1 (en) | 2007-07-17 | 2009-01-21 | Chemo Ibérica, S.A. | Novel one step process for preparing cross-linked poly(allylamine) polymers |
WO2009023544A2 (en) | 2007-08-10 | 2009-02-19 | Ilypsa, Inc. | Dosage unit anion-exchange polymer pharmaceutical compositions |
US20090156647A1 (en) | 2007-12-12 | 2009-06-18 | Iovate T. & P. Inc. | Method for maintaining physiological pH levels during intensive physical exercise |
PA8807201A1 (es) | 2007-12-14 | 2009-07-23 | Genzyme Corp | Composiciones farmaceuticas |
JP2011506449A (ja) | 2007-12-14 | 2011-03-03 | ジェンザイム コーポレーション | コーティング医薬組成物 |
WO2009097127A1 (en) | 2008-01-31 | 2009-08-06 | Genzyme Corporation | Pharmaceutical compositions |
WO2009114650A1 (en) | 2008-03-11 | 2009-09-17 | Chakshu Research, Inc. | Methods and compositions for treating inflammation and inflammation-related pathologies |
US20100331516A1 (en) | 2008-04-08 | 2010-12-30 | Govind Dhananjay Sathe | Process for Preparation of Sevelamer Carbonate |
ES2380162T3 (es) | 2008-04-11 | 2012-05-09 | Gp Investimenti S.R.L. | Dispositivo de uso manual para el tratamiento de tejido humano con ultrasonidos |
WO2009154747A1 (en) | 2008-06-20 | 2009-12-23 | Genzyme Corporation | Pharmaceutical compositions |
DE102008030046A1 (de) | 2008-06-25 | 2009-12-31 | Ratiopharm Gmbh | Kompaktiertes Polyallylamin-Polymer |
US20100008988A1 (en) | 2008-07-14 | 2010-01-14 | Glenmark Generics, Ltd. | Tablet compositions of amine polymers |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
US20100104527A1 (en) | 2008-08-22 | 2010-04-29 | Relypsa, Inc. | Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties |
WO2010022380A2 (en) | 2008-08-22 | 2010-02-25 | Relypsa, Inc. | Linear polyol stabilized polyfluoroacrylate compositions |
CA2737452C (en) | 2008-09-25 | 2018-05-22 | Vive Nano Inc. | Methods to produce polymer nanoparticles and formulations of active ingredients |
WO2010035273A2 (en) | 2008-09-29 | 2010-04-01 | Intec Pharma Ltd. | Novel gastroretentive delivery system |
WO2010059384A1 (en) | 2008-10-30 | 2010-05-27 | Janssen Pharmaceutica Nv | Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists |
US20100166861A1 (en) | 2008-12-29 | 2010-07-01 | Kelly Noel Lynch | Pharmaceutical formulations of sevalamer, or salts thereof, and copovidone |
AU2010209293A1 (en) | 2009-01-22 | 2011-09-08 | Usv Limited | Pharmaceutical compositions comprising phosphate-binding polymer |
US8945508B2 (en) | 2009-10-13 | 2015-02-03 | The Regents Of The University Of Michigan | Dendrimer compositions and methods of synthesis |
DK2490675T3 (en) | 2009-10-22 | 2019-04-29 | Synthon Bv | Pharmaceutical compositions with sevelamer |
WO2011071927A2 (en) | 2009-12-07 | 2011-06-16 | Ironwood Pharmaceuticals, Inc. | Treatments for gastrointestinal disorders |
WO2011106542A2 (en) | 2010-02-24 | 2011-09-01 | Relypsa, Inc. | Crosslinked polyvrnylamine, poly all ylamine, and polyethyleneimine for use as bile acid sequestrants |
AU2011220745B2 (en) | 2010-02-24 | 2016-12-01 | Relypsa, Inc. | Polyimidazoles for use as bile acid sequestrants |
RU2417782C1 (ru) * | 2010-03-03 | 2011-05-10 | Федеральное государственное образовательное учреждение высшего профессионального образования "Белгородская государственная сельскохозяйственная академия" | Способ лечения ацидоза рубца |
IT1406068B1 (it) | 2010-07-22 | 2014-02-06 | Medestea Int Spa | Polidesossiribonucleotidi (pdrn) per l'impiego nel trattamento di condizioni di acidosi e composizioni a base di polidesossiribonucleotidi per il suddetto impiego |
US20130156720A1 (en) | 2010-08-27 | 2013-06-20 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
KR101238210B1 (ko) | 2011-06-30 | 2013-03-04 | 엘지전자 주식회사 | 이동 단말기 |
US20130137772A1 (en) | 2011-11-29 | 2013-05-30 | Raymond J. Bergeron | Hydroxypolyamine salts |
EA201590062A1 (ru) | 2012-06-21 | 2016-02-29 | Керикс Байофармасьютикалз, Инк. | Применение лимонно-кислого железа при лечении пациентов с хронической почечной недостаточностью |
CA2886788C (en) | 2012-10-08 | 2022-04-19 | Relypsa, Inc. | Potassium-binding agents for treating hypertension and hyperkalemia |
AU2014274817B2 (en) | 2013-06-05 | 2019-05-23 | Tricida, Inc. | Proton-binding polymers for oral administration |
BR112016009901A8 (pt) | 2013-11-04 | 2020-04-14 | Keryx Biopharmaceuticals Inc | uso de citrato férrico |
ES2857177T3 (es) | 2014-12-10 | 2021-09-28 | Tricida Inc | Polímeros de unión de protones para administración oral |
SG11201809605PA (en) | 2016-05-06 | 2018-11-29 | Tricida Inc | Compositions for and method of treating acid-base disorders |
SG11202003451UA (en) | 2017-11-03 | 2020-05-28 | Tricida Inc | Compositions for and method of treating acid-base disorders |
US20210187011A1 (en) | 2017-11-03 | 2021-06-24 | Tricida, Inc. | Method of treating acid-base disorders |
WO2019236639A1 (en) | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
WO2019236636A1 (en) | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
WO2019236124A1 (en) | 2018-06-04 | 2019-12-12 | Tricida, Inc. | Method of treating acid-base disorders |
-
2014
- 2014-06-05 AU AU2014274817A patent/AU2014274817B2/en active Active
- 2014-06-05 PL PL14742001T patent/PL3003327T3/pl unknown
- 2014-06-05 ES ES17177221T patent/ES2733493T3/es active Active
- 2014-06-05 LT LTEP14742001.2T patent/LT3003327T/lt unknown
- 2014-06-05 SI SI201431241T patent/SI3287133T1/sl unknown
- 2014-06-05 KR KR1020157036999A patent/KR102318910B1/ko active IP Right Grant
- 2014-06-05 TR TR2019/09355T patent/TR201909355T4/tr unknown
- 2014-06-05 PT PT17177221T patent/PT3287133T/pt unknown
- 2014-06-05 RS RS20201307A patent/RS61005B1/sr unknown
- 2014-06-05 CN CN201480032395.1A patent/CN105377270B/zh active Active
- 2014-06-05 EP EP20183421.5A patent/EP3812761A1/en active Pending
- 2014-06-05 ES ES19169259T patent/ES2834485T3/es active Active
- 2014-06-05 HU HUE17177221A patent/HUE043999T2/hu unknown
- 2014-06-05 HU HUE14742001A patent/HUE034836T2/en unknown
- 2014-06-05 BR BR112015030142-8A patent/BR112015030142B1/pt active IP Right Grant
- 2014-06-05 DK DK19169259.9T patent/DK3578185T3/da active
- 2014-06-05 DK DK17177221.3T patent/DK3287133T3/da active
- 2014-06-05 PT PT147420012T patent/PT3003327T/pt unknown
- 2014-06-05 HU HUE19169259A patent/HUE051198T2/hu unknown
- 2014-06-05 RU RU2015155596A patent/RU2728778C2/ru active
- 2014-06-05 SI SI201430466T patent/SI3003327T1/en unknown
- 2014-06-05 DK DK14742001.2T patent/DK3003327T3/en active
- 2014-06-05 PL PL17177221T patent/PL3287133T3/pl unknown
- 2014-06-05 WO PCT/US2014/041152 patent/WO2014197725A1/en active Application Filing
- 2014-06-05 MX MX2015016527A patent/MX364785B/es active IP Right Grant
- 2014-06-05 SI SI201431698T patent/SI3578185T1/sl unknown
- 2014-06-05 LT LTEP19169259.9T patent/LT3578185T/lt unknown
- 2014-06-05 JP JP2016518006A patent/JP6453860B2/ja active Active
- 2014-06-05 KR KR1020247003745A patent/KR20240023672A/ko active Search and Examination
- 2014-06-05 EP EP17177221.3A patent/EP3287133B1/en active Active
- 2014-06-05 CN CN202010780604.8A patent/CN111671767B/zh active Active
- 2014-06-05 PT PT191692599T patent/PT3578185T/pt unknown
- 2014-06-05 RS RS20190806A patent/RS59033B1/sr unknown
- 2014-06-05 KR KR1020217034420A patent/KR20210131457A/ko not_active Application Discontinuation
- 2014-06-05 KR KR1020237024806A patent/KR102633597B1/ko active IP Right Grant
- 2014-06-05 CN CN202010780603.3A patent/CN111671766B/zh active Active
- 2014-06-05 ES ES14742001.2T patent/ES2646271T3/es active Active
- 2014-06-05 EP EP14742001.2A patent/EP3003327B1/en active Active
- 2014-06-05 LT LTEP17177221.3T patent/LT3287133T/lt unknown
- 2014-06-05 EP EP19169259.9A patent/EP3578185B1/en active Active
- 2014-06-05 CA CA2912911A patent/CA2912911C/en active Active
- 2014-06-23 US US14/311,852 patent/US9205107B2/en active Active
-
2015
- 2015-01-27 NO NO15000230A patent/NO2905572T3/no unknown
- 2015-11-18 US US14/944,844 patent/US9925214B2/en active Active
- 2015-11-24 IL IL242758A patent/IL242758B/en active IP Right Grant
- 2015-12-01 MX MX2021013880A patent/MX2021013880A/es unknown
- 2015-12-01 MX MX2019005300A patent/MX2019005300A/es unknown
-
2016
- 2016-08-30 HK HK16110308.8A patent/HK1222120A1/zh unknown
- 2016-10-05 HK HK16111588.7A patent/HK1223288A1/zh unknown
-
2017
- 2017-09-26 US US15/715,934 patent/US9993500B2/en active Active
- 2017-10-18 HR HRP20171590TT patent/HRP20171590T1/hr unknown
- 2017-11-06 CY CY20171101159T patent/CY1119611T1/el unknown
-
2018
- 2018-06-07 US US16/002,269 patent/US10363268B2/en active Active
- 2018-06-07 US US16/002,306 patent/US10391118B2/en active Active
- 2018-08-16 HK HK18110550.1A patent/HK1251151B/zh unknown
- 2018-12-13 JP JP2018233254A patent/JP6759316B2/ja active Active
-
2019
- 2019-04-04 US US16/375,843 patent/US10369169B1/en active Active
- 2019-06-14 HR HRP20191074TT patent/HRP20191074T1/hr unknown
- 2019-07-04 CY CY20191100694T patent/CY1121801T1/el unknown
- 2019-08-16 US US16/542,969 patent/US11197887B2/en active Active
- 2019-08-22 AU AU2019219800A patent/AU2019219800B1/en active Active
- 2019-12-04 AU AU2019275584A patent/AU2019275584B2/en active Active
-
2020
- 2020-01-09 IL IL271932A patent/IL271932B/en active IP Right Grant
- 2020-09-02 JP JP2020147224A patent/JP7075455B2/ja active Active
- 2020-10-20 IL IL278183A patent/IL278183B/en unknown
- 2020-10-30 CY CY20201101028T patent/CY1123673T1/el unknown
- 2020-11-02 HR HRP20201767TT patent/HRP20201767T1/hr unknown
-
2021
- 2021-12-09 US US17/546,339 patent/US20220096534A1/en active Pending
-
2022
- 2022-05-13 JP JP2022079329A patent/JP2022107004A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1123673T1 (el) | Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος | |
CY1124073T1 (el) | Πολυμερη συνδεσης πρωτονιου για χορηγηση απο του στοματος | |
CY1122480T1 (el) | Μεθυλικη βαρδοξολονη για τη θεραπεια παχυσαρκιας | |
CY1124298T1 (el) | Φενφλουραμινη για χρηση στην θεραπευτικη αντιμετωπιση του συνδρομου dravet | |
MY197091A (en) | Compositions for treating acid-base disorders | |
CY1123052T1 (el) | Συνθεσεις και μεθοδοι σχετικες με παραλλαγες της πρωτεϊνες α (spa) | |
CY1121041T1 (el) | Μεθοδοι αγωγης παιδιατρικων ασθενων με τη χρηση δεξμεδετομιδινης | |
CY1122129T1 (el) | Μεθοδοι για αγωγη πνευμονικων μη-φυματιωδων μυκοβακτηριακων λοιμωξεων | |
CY1122078T1 (el) | Θεραπευτικα νανοσωματιδια που εμπεριεχουν θεραπευτικο παραγοντα και μεθοδοι παρασκευης και χρησης αυτων | |
CY1121736T1 (el) | Άλατα aramchol | |
CY1119213T1 (el) | Πρωτεϊνη p75ntr συνδεσης νευροτροφινης για θεραπευτικη χρηση | |
CY1117869T1 (el) | Φαρμακοτεχνικες μορφες για απο του στοματος απελευθερωση προσροφητικων στο εντερο | |
CY1118813T1 (el) | Φαρμακευτικες συνθεσεις συν-κρυσταλλων τραμαδολης και κοξιμπων | |
EA201591679A1 (ru) | Способ нетоксического лечения абстиненции, вызванной лекарственным средством | |
CY1116840T1 (el) | Χρηση 24-norudca | |
CY1122882T1 (el) | Παραγωγα 3-(καρβοξυαιθυλ)-8-αμινο-2-οξο-1,3-διαζα-σπειρο-[4.5]-δεκανιου | |
CY1121222T1 (el) | Ιατρικη κολλα και μεθοδος παραγωγης της | |
CY1120835T1 (el) | Ταυρο-ουρσοδεοξυχολικο οξυ (tudca) για χρηση στη θεραπεια νευροεκφυλιστικων διαταραχων | |
CY1126127T1 (el) | Παρασκευασμα που περιεχει γαλακτοβακιλλους reuteri και κιτρικο οξυ για ιατρικη χρηση | |
CY1117795T1 (el) | Φαρμακευτικες συνθεσεις απαλλαγμενες κιτρικου αλατος οι οποιες περιεχουν ανακινρα | |
EA201500765A1 (ru) | Способы лечения сердечно-сосудистых заболеваний | |
CY1121708T1 (el) | Ενωσεις ουριας ινδανυλιου που αναστελλουν την ρ38 map kιναση | |
UA112488C2 (uk) | Три(гетеро)арилпіразоли і їх застосування | |
CY1120381T1 (el) | Μεθοδος για την αγωγη και τη θεραπεια της λεϊσμανιασης δια της χρησεως φεξινιδαζολης | |
RU2012100120A (ru) | Акарицидная фармацевтическая композиция на основе соли четвертичного фосфония, замещенного динитробензофураксана и ксимедонгидрохлорида |